Related Experiment Video
Updated: Mar 6, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Revealing oral medication patterns from reconstructed long-term medication history of type 2 diabetes
Abstract:
With the growing attention to evidence-based medical guideline development, longitudinal analysis of Electronic Medical Records (EMR) has become a good tool for providing insight into and new knowledge on the existing therapy. For chronic diseases, longitudinal analysis of medication history plays a key role in reaching this goal. However, raw medication data in EMR are not suitable for longitudinal analysis for several reasons. First, many prescriptions have a short duration. Second, the prescription duration may have a gap or overlap with other prescription durations. Additionally, for diabetes cases, physicians must wait for a certain period to observe the effectiveness of the medication. However, the existing methods do not address these conditions. To tackle these issues, we propose a set of rules for medication episode reconstruction. We then apply the rules for longitudinal analysis on anonymous Type 2 diabetes patients' EMR provided by Kyoto University Hospital. The EMR span from 2000 to 2015. Two of our significant results are as follows: (1) our proposed medication episode reconstruction method is able to compress the search space into 23.83% compared to the raw data, and (2) the preliminary results show the benefits of the method in revealing the existing medication patterns over the years and unfamiliar therapy transition.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin Formulations: Types and Delivery
Short-acting insulins are divided into...
Diabetes Mellitus: Type 2 and Gestational
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Oral Hypoglycemic Agents: Biguanides and Glitazones

